Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-09-18 Sale |
2020-09-22 8:10 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
3,035 | $86.87 | $263,636 | 3,969,319 (Indirect Direct) |
View |
| 2020-09-16 Sale |
2020-09-18 4:30 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
8,965 | $86.98 | $779,777 | 3,972,354 (Indirect Direct) |
View |
| 2020-09-14 Sale |
2020-09-16 8:00 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
1,155 | $84.89 | $98,045 | 3,981,319 (Indirect Direct) |
View |
| 2020-09-10 Sale |
2020-09-11 9:49 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
22,845 | $85.36 | $1,949,996 | 2,152,425 (Indirect Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 9:21 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
60,000 | $92.51 | $5,550,644 | 4,223,064 (Indirect) |
View |
| 2020-09-01 Sale |
2020-09-03 4:46 pm |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $92.26 | $1,107,068 | 156,410 (Direct) |
View |
| 2020-09-01 Sale |
2020-09-03 4:44 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $92.62 | $2,315,578 | 975,215 (Direct) |
View |
| 2020-08-19 Sale |
2020-08-21 4:11 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $100 | $2,500,000 | 763,833 (Direct) |
View |
| 2020-08-03 Sale |
2020-08-05 4:20 pm |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $86.74 | $1,040,919 | 168,410 (Direct) |
View |
| 2020-07-07 Sale |
2020-07-09 4:00 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $90 | $2,250,000 | 788,833 (Direct) |
View |
| 2020-07-06 Sale |
2020-07-08 4:00 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
20,000 | $82.39 | $1,647,730 | 4,163,064 (Indirect) |
View |
| 2020-07-01 Sale |
2020-07-06 4:14 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $80 | $4,000,000 | 648,007 (Direct) |
View |
| 2020-06-24 Sale |
2020-06-26 4:33 pm |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
70,000 | $75.88 | $5,311,564 | 42,244 (Direct) |
View |
| 2020-06-23 Sale |
2020-06-25 4:28 pm |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
50,000 | $75 | $3,750,000 | 698,007 (Direct) |
View |
| 2020-06-22 Sale |
2020-06-24 7:02 pm |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
20,000 | $73.93 | $1,478,522 | 4,183,064 (Indirect) |
View |
| 2020-06-22 Sale |
2020-06-24 5:58 pm |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
7,158 | $75.04 | $537,123 | 33,747 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-05 Option Award |
2020-10-06 5:34 pm |
N/A 2030-10-05 |
CRISPR Therapeutics AG | CRSP | KASINGER JAMES R. General Counsel and Secretary |
11,666 | $0 | 11,666 (Direct) |
View |
| 2020-10-05 Option Award |
2020-10-06 5:32 pm |
N/A 2030-10-05 |
CRISPR Therapeutics AG | CRSP | Ho Tony W Executive VP, Head of R&D |
16,666 | $0 | 16,666 (Direct) |
View |
| 2020-09-22 Other |
2020-09-24 6:09 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
429,596 | $0 | 2,421,474 (Indirect) |
View |
| 2020-09-09 Other |
2020-09-11 9:49 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
214,799 | $0 | 2,152,425 (Indirect) |
View |
| 2020-09-01 Exercise |
2020-09-03 9:21 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
30,000 | $14 | 4,223,064 (Indirect) |
View |
| 2020-09-01 Exercise |
2020-09-03 9:21 pm |
N/A 2026-10-18 |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
60,000 | $0 | 4,223,064 (Indirect) |
View |
| 2020-09-01 Exercise |
2020-09-03 9:21 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
15,000 | $59.31 | 4,223,064 (Indirect) |
View |
| 2020-09-01 Exercise |
2020-09-03 9:21 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Bolzon Bradley J PhD Director |
15,000 | $13.62 | 4,223,064 (Indirect) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:46 pm |
N/A 2027-11-21 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $0 | 156,410 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:46 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $17.75 | 156,410 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
3,933 | $14 | 975,215 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:44 pm |
N/A 2026-10-18 |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $0 | 975,215 (Direct) |
View |
| 2020-09-01 Exercise |
2020-09-03 4:44 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
21,067 | $14.43 | 975,215 (Direct) |
View |
| 2020-09-02 Tax Withholding |
2020-09-03 4:42 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Kulkarni Samarth Chief Executive Officer |
779 | $94.15 | 169,968 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 4:11 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $14 | 763,833 (Direct) |
View |
| 2020-08-19 Exercise |
2020-08-21 4:11 pm |
N/A 2026-10-18 |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $0 | 763,833 (Direct) |
View |
| 2020-08-13 Other |
2020-08-14 4:30 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Behbahani Ali Director |
71 | $0 | 341 (Direct) |
View |
| 2017-11-13 Exercise |
2020-08-05 4:20 pm |
N/A 2027-11-21 |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $0 | 168,410 (Direct) |
View |
| 2020-08-03 Exercise |
2020-08-05 4:20 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | TOMSICEK MICHAEL JOHN Chief Financial Officer |
12,000 | $17.75 | 168,410 (Direct) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
19,414 | $14 | 788,833 (Direct) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:00 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
5,586 | $1.81 | 788,833 (Direct) |
View |
| 2020-07-07 Exercise |
2020-07-09 4:00 pm |
N/A 2025-09-10 |
CRISPR Therapeutics AG | CRSP | Novak Rodger President |
25,000 | $0 | 788,833 (Direct) |
View |
| 2020-06-24 Exercise |
2020-06-26 4:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
38,666 | $5.86 | 42,244 (Direct) |
View |
| 2020-06-24 Exercise |
2020-06-26 4:33 pm |
N/A 2026-03-01 |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
70,000 | $0 | 42,244 (Direct) |
View |
| 2020-06-24 Exercise |
2020-06-26 4:33 pm |
N/A N/A |
CRISPR Therapeutics AG | CRSP | Klein Lawrence Otto CBO & COO |
31,334 | $12.57 | 42,244 (Direct) |
View |